$0.17
0.00 (-0.47%)
Open$0.18
Previous Close$0.17
Day High$0.18
Day Low$0.17
52W High$1.48
52W Low$0.16
Volume—
Avg Volume395.9K
Market Cap17.75M
P/E Ratio—
EPS$-5.52
SectorN/A
Analyst Ratings
Buy
9 analysts
Price Target
+2,211.8% upside
Current
$0.17
$0.17
Target
$3.93
$3.93
$2.76
$3.93 avg
$6.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.40B | 1.28B | 17.89M |
| Net Income | -558,098,633 | -458,962,691 | 2.66M |
| Profit Margin | -39.8% | -37.8% | 14.8% |
| EBITDA | -419,424,690 | -364,083,932 | 4.50M |
| Free Cash Flow | — | — | 2.54M |
| Rev Growth | +9.4% | +9.4% | -6.4% |
| Debt/Equity | 6.52 | 6.52 | 0.53 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $0.96 | -21.55% | — | 1.23B |
| PICS | Pics Nv | $6.96 | -3.06% | 3.7 | 888.97M |
| DMII | Drugs Made In America Acquis | $10.26 | +0.29% | 50.0 | 651.01M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.61 | +0.09% | 27.6 | 219.04M |
| CEPF | Cantor Equity Partners-Cl A | $10.35 | +0.00% | 41.5 | 589.79M |